Vice President Employee Benefits, USI Insurance Services | Health Insurance Specialist
Patient Access is changing - Eli Lilly has announced direct to consumer access for through LillyDirect. For Plan Sponsors this is a time when education and employee experience remains challenging. As the U.S. Economy continues on a turbulent path, employers still face increased pressure from the employee benefits expense line, expensive treatments will continue to rise including new and emerging cell and gene therapies, GLP-1's and specialty drugs will outpace their usual significant increase on total claims. The GLP-1 Market is set to value at $71B by 2032* (JP Morgan market projection). The USI pharmacy team helps clients evaluate and implement various solutions to control the impact of prescriptions drugs on health plan spending.
